Pre-extensively Drug-resistant Tuberculosis
📧 Sign up to get email alerts when something new happens for Pre-extensively Drug-resistant Tuberculosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB) [Phase 3]
Phase 3 INSPIRE-TB trial evaluating an all-oral, shorter, individualized regimen for rifampicin-resistant tuberculosis, including multidrug-…